⬢ We are in a position to take advantage of rising demand and legislative changes that pave the way for a medicinal and nutraceuticals cannabis industry worldwide.
⬢ We have a well-defined strategy and road-map, with clear milestones to be achieved and will continue to be transparent about our KPI’s and milestones.
⬢ Our business goals are aligned to environmental responsibility. We will look for opportunities and technology to ensure our practices are sustainable.
⬢ Our R&D strategy will position us to develop proprietary IP and set an elevated benchmark as pioneers and leaders in the industry. This will ensure we deliver advanced, high-quality medicinal and nutraceutical cannabis products, with assurance from seed-to-sale.
⬢ Our strong offshore partnerships are opening doors to international opportunities.
⬢ Our Board of Directors have strong governance and management experience and expertise in science and medicine.
⬢ We forecast that we will start generating revenue in early 2021 with projected earnings showing a substantial return-on-investment and attractive dividend policy.